Abstract:Sudden cardiac death (SCD) remains a major public health problem responsible for more than 400,000 deaths annually in the United States.1 With the recognition of ventricular tachyarrhythmias as the major cause of SCD, and the failure of antiarrhythmic drugs to impact the incidence of this problem, there is increasing use of the implantable cardioverter defibrillator (ICD) as primary prevention. ICD therapy saves lives, but it is costly and associated with morbidity, both from the invasive implantation procedure and subsequent appropriate or inappropriate pacing and shocks. Moreover, only about onethird of primary prevention patients receiving ICD in clinical trials will experience an appropriate shock in the first four to five years of treatment, and most patients with SCD do not meet present guidelines for prophylactic ICD implantation. Accordingly, better risk stratification is needed to identify high-risk cohorts for SCD. Current guidelines for the selection of primary prevention ICD candidates rely primarily on clinical symptoms (i.e., heart failure) and the presence of coronary artery disease and left ventricular systolic function. However, an abundance of studies shows that the electrophysiologic substrate also influences the risk of sudden death and ventricular tachyarrhythmias. Many of these studies identified changes of ventricular repolarization as critical to sustain life-threatening arrhythmias. QT dispersion, QT variability, and T-wave abnormalities have all been evaluated. Probably the best studied and most accepted measure of repolarization used to assess arrhythmia vulnerability is microvolt T-wave alternans (TWA). T-wave alternans quantifies the changes of timing and magnitude of the T-wave that occur on an every-other-beat basis. Studies have shown the prognostic value of this test to predict arrhythmic events directly or the surrogate markers of arrhythmia vulnerability in a wide variety of patients, typically at moderately elevated heart rates.2-5 Recently, it was proposed that TWA can be used to subselect patients for ICD implantation who met standard clinical indications for such therapy.6 However, a prospective study of SCD-HeFT failed to confirm the value of TWA testing when evaluated for the first time in a cohort randomized to receive ICD therapy.7 One of the issues raised with these studies, and a possible explanation for such disparate results, is that TWA results are not stable over time. To use a dynamic process

D ec 2 00 1 1 Topology of Center Vortices 1 H

High-performance liquid chromatographic determination of trazodone and 1-m-chlorophenylpiperazine with ultraviolet and electrochemical detector

Statistical Design Approach for Optimizing the Spectrofluorimetric Method for Quantifying Trazodone Hydrochloride

Dynamic Changes of T‐Wave Alternans: Does It Predict Short‐Term Arrhythmia Vulnerability?

Sensitive extractive spectrophotometric methods for the determination of trazodone hydrochloride in pharmaceutical formulations

A green micelle‐enhanced first derivative synchronous fluorescence approach for determination of donepezil HCl and trazodone HCl in their pure state, pharmaceutical dosage form and spiked human plasma

Despeckling of Ultrasound Medical Images: A Survey

Validated thin-layer chromatographic–densitometric and high-performance liquid chromatographic methods for the simultaneous determination of alfuzosin and tadalafil in pharmaceutical products

Determination of Terazosin in Human Plasma by HPLC with Fluorescence Detection

Determination of tricyclic antidepressants in human urine samples by the three-step sample pretreatment followed by HPLC-UV analysis: an efficient analytical method for further pharmacokinetic and forensic studies

Utility of 7,7,8,8-tetracyanoquinodimethane charge transfer reagent for the spectrophotometric determination of trazodone, amineptine and amitriptyline hydrochlorides

Hollow-fiber liquid phase microextraction for determination of fluoxetine in human serum by nano-liquid chromatography coupled to high resolution mass spectrometry

An algorithm for intelligent audio watermaking using genetic algorithm

Spectrophotometric determination of trazodone, amineptine and amitriptyline hydrochlorides through ion-pair formation using methyl orange and bromocresol green reagents

Spectrophotometric determination of trazodone, amineptine and amitriptyline hydrochlorides through ion-pair formation with molybdenum and thiocyanate

Determination of Dextromethorphan and Its Metabolite Dextrorphan in Human Urine by Capillary Gas Chromatography Without Derivatization

Quantification of a New Antifungal Drug Based on 1,3,4-Thiadiazole by HPLC-ESI/MS: Method Development, Validation and Pharmacokinetic Application

Determination of Letrozole in Pharmaceutical Preparation and Human Plasma Based on Fluorometric Detection

A powerful combination of quadruple isotope dilution strategy with dispersive magnetic solid phase extraction for the accurate and precise multi-analyte determination of tadalafil, sildenafil, avanafil and vardenafil in human plasma and urine samples using LC-ESI-Tandem MS

Determination of Zopiclone in Plasma by High-performance Liquid Chromoto- Graphy with Fluorescent Detection

Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.